Scotland · NHS Scotland MSAN
Hormone Replacement Therapy (all formulations)
MSAN(2020)67 · Level 3 · issued 23 Jul 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| supply issues. The table also provides an update of all HRT preparations that remain available. | Available | — |
| support local decision making is available through various sources such as the British National | Available | — |
| bazedoxifene 20mg Pfizer Duavive 300mcg/ Discontinued | Discontinued | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2020:67
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
bd0006c19c16a5510165d5de22c3915c1a7ab8e7b8a1b87a05e77e146cbf5981sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2020-67.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.